Michael Jeltsch

RSS feed of this list

  1. Key molecules in lymphatic development, function, and identification

    Jha, S. K., Rauniyar, K. & Jeltsch, M., 2018, In : Annals of Anatomy. 219, p. 25-34 10 p.

    Research output: Contribution to journalReview ArticleScientificpeer-review

  2. Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels

    Rauniyar, K., Jha, S. K. & Jeltsch, M. M., 12 Feb 2018, In : Frontiers in Bioengineering and Biotechnology. 6, 12 p., 7

    Research output: Contribution to journalReview ArticleScientificpeer-review

  3. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1

    Jha, S. K., Rauniyar, K., Kärpänen, T., Leppänen, V-M., Brouillard, P., Vikkula, M., Alitalo, K. & Jeltsch, M., 7 Jul 2017, In : Scientific Reports. 7, 13 p., 4916

    Research output: Contribution to journalArticleScientificpeer-review

  4. Factors regulating the substrate specificity of cytosolic phospholipase A(2)-alpha in vitro

    Batchu, K. C., Hänninen, S., Jha, S. K., Jeltsch, M. & Somerharju, P., Nov 2016, In : Biochimica and Biophysica Acta. Molecular and Cell Biology of Lipids. 1861, 11, p. 1597-1604 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

  5. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis

    Johns, S. C., Yin, X., Jeltsch, M., Bishop, J. R., Schuksz, M., El Ghazal, R., Wilcox-Adelman, S. A., Alitalo, K. & Fuster, M. M., 8 Jul 2016, In : Circulation Research. 119, 2, p. 210-+ 24 p.

    Research output: Contribution to journalArticleScientificpeer-review

  6. Methods and uses related to ADAMTS3

    Alitalo, K., Jeltsch, M., Jha, S. K. & Tvorogov, D., 30 Jul 2015, WIPO, Patent No. WO2015/110707, 30 Jul 2015, Priority date 24 Jan 2014, Priority No. 20145073 (FI)

    Research output: PatentScientific

  7. Therapeutic use of VEGF-C and CCBE1

    Alitalo, K., Jeltsch, M. & Anisimov, A., 19 Feb 2015, WIPO, Patent No. WO2015/022447, 15 Feb 2015, Priority date 14 Aug 2013, Priority No. 20135832 (FI)

    Research output: PatentScientific

  8. VEGFR-2-specific forms of VEGF-D and VEGF-C and uses thereof

    Alitalo, K. K., Jeltsch, M. M., Leppänen, V-M., Aho, K. K., Anisimov, A. & Tvorogov, D., 5 Jul 2012, WIPO, Patent No. WO2012/088563, 2 Jul 2012, Priority date 24 Nov 2010, Priority No. 61/458,517 (US)

    Research output: PatentScientific

  9. Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B: patent application

    Jeltsch, M. M., Alitalo, K. K., Olofsson, B. & Eriksson, U., 6 Jun 2002, US Patent and Trademark Office, Patent No. US 2001/0068694 A1, 6 Jun 2002, Priority date 26 Jun 2000, Priority No. 60/220,824

    Research output: PatentScientific

  10. Growth factor binding constructs, materials and methods

    Alitalo, K. K. & Jeltsch, M. M., 21 Dec 2010, US Patent and Trademark Office, Patent No. US 7,855,178 B2, 21 Dec 2010, Priority date 5 Mar 2004, Priority No. 60/550,907

    Research output: PatentScientific

Previous 1 2 3 4 5 6 7 Next